NCT05556096 2026-04-21
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 3 Active not recruiting
Clinical Trials
14 trialsNCT05644561 2026-04-17
Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 3 Active not recruiting
NCT05403541 2026-03-25
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
Immunovant Sciences GmbH
Phase 3 Active not recruiting
NCT04524273 2026-03-10
MINT
Amgen
Phase 3 Active not recruiting
NCT00716066 2026-02-27
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Fred Hutchinson Cancer Center
Phase 2 Active not recruiting
NCT04225871 2026-02-27
RAISE-XT
UCB Pharma
Phase 3 Active not recruiting
NCT06359041 2026-02-20
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Cabaletta Bio
Phase 1/2 Active not recruiting
NCT05070858 2026-02-12
NIMBLE
Regeneron Pharmaceuticals
Phase 3 Active not recruiting
NCT05150210 2025-12-23
SP Thoracic IDE Study
Intuitive Surgical
Phase NA Active not recruiting
NCT06558279 2025-12-15
ADAPT oculus
argenx
Phase 3 Active not recruiting
NCT06298552 2025-11-05
ADAPT SERON
argenx
Phase 3 Active not recruiting
NCT06282159 2025-10-07
MAGIC
Dianthus Therapeutics
Phase 2 Active not recruiting
NCT07071246 2025-07-17
Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
Tang-Du Hospital
Phase NA Active not recruiting
NCT04146051 2025-05-28
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
Cartesian Therapeutics
Phase 2 Active not recruiting